CPO and infection: The sustained release capabilities of these NPs for H2O2 have been demonstrated, alongside their effectiveness in infection control and tissue regeneration facilitation.[11] Nonetheless, current research approaches have predominantly employed the encapsulation of CPO NPs within nanocarriers or hydrogel vehicles as prodrugs.[12] The application of CPO NPs directly to wounds still presents potential risks, such as the over‐accumulation of H2O2,[8b] which could incite unwarranted inflammatory responses.